BeStock  

Teamshares TMS

US equityMarket cap rank #3723Financial Conglomerates
$3.91 −$0.24 (-5.78%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $3.91 0.00%
Open$4.03
Prev close$4.15
Day range$3.88 – $4.31
Volume82.8K
Market cap$283.47M
P/E (TTM)–
Dividend yield–

TMS Stock News

Headlines matching Teamshares or the TMS ticker, most recent first.

  • TMS: Our Chairman of the Board, Keiji Hasumi (Distinguished Professor at Tokyo University of Agriculture and Technology), will appear on NHK E-TV's program "The Villains' Side of the Story."JPX · 7 Sep 2026 · Direct mention
  • EDAP TMS | 4: Statement of changes in beneficial ownership of securities-Officer Mobeck Kenneth S.SEC · 17 Aug 2026 · Direct mention
  • EDAP TMS | 4: Statement of changes in beneficial ownership of securities-Director Horn David R.SEC · 17 Aug 2026 · Direct mention
  • EDAP TMS S.A. Q2 2026 Earnings PreviewSeeking Alpha · 13 Aug 2026 · Direct mention
  • Mizuho Securities Initiates EDAP TMS(FOCL.US) With Buy Rating, Announces Target Price $15Market news · 17 Jul 2026 · Direct mention
  • Northland Securities Initiates Teamshares(TMS.US) With Buy Rating, Announces Target Price $14Market news · 16 Jul 2026 · Direct mention
  • H.C. Wainwright Maintains EDAP TMS(EDAP.US) With Buy Rating, Maintains Target Price $10Market news · 8 May 2026 · Direct mention
  • EDAP TMS: EDAP TMS S.A. - Symbol Change Option Symbol: EDAP New Symbol: FOCLOCC · 30 May 2026 · Direct mention
  • EDAP TMS | 4: Statement of changes in beneficial ownership of securities-Officer Mobeck Kenneth S.SEC · 13 May 2026 · Direct mention
  • H.C. Wainwright Maintains EDAP TMS(EDAP.US) With Buy Rating, Cuts Target Price to $10 NegativeMarket news · 9 Apr 2026 · Direct mention
  • TMS Co., Ltd. Posts Continued Losses but Maintains Strong Equity Base in Shortened Fiscal Year MixedTipRanks · 13 Feb 2026 · Direct mention
  • Lucid Capital Maintains EDAP TMS(FOCL.US) With Buy Rating, Cuts Target Price to $8 NegativeMarket news · 6 Nov 2026 · Direct mention
  • H.C. Wainwright Maintains EDAP TMS(FOCL.US) With Buy Rating, Maintains Target Price $10Market news · 4 Nov 2026 · Direct mention
  • TMS: The research team of the GLORIA clinical trial for glioblastoma, which utilizes NOX-A12, has been awarded the "German University Medicine Prize" — recognizing its innovative therapeutic approach and outstanding clinical trial results.JPX · 4 Nov 2026 · Direct mention
  • BrainsWay Expands U.S. Insurance Coverage for Deep TMS Treatment of OCD to Over 118 Million Lives PositiveGlobeNewswire · 26 Oct 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on TMS.

Sign in to join the discussion.

Scroll to Top